{"id":"https://openalex.org/W4403405973","doi":null,"title":"[New outcome studies with injectable semaglutide in different at risk populations].","display_name":"[New outcome studies with injectable semaglutide in different at risk populations].","alternate_titles":[],"publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403405973","pmid":"https://pubmed.ncbi.nlm.nih.gov/39397557"},"language":"fr","primary_location":{"id":"pmid:39397557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39397557","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue medicale de Liege","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W4403405973"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://orbi.uliege.be/bitstream/2268/325026/1/ScheenRevMedLiege2024.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]},{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andr\u00e9 Scheen","raw_affiliation_strings":["Service de Diab\u00e9tologie, Nutrition et Maladies m\u00e9taboliques et Unit\u00e9 de Pharmacologie clinique, CHU Li\u00e8ge, ULi\u00e8ge, Belgique"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Diab\u00e9tologie, Nutrition et Maladies m\u00e9taboliques et Unit\u00e9 de Pharmacologie clinique, CHU Li\u00e8ge, ULi\u00e8ge, Belgique","institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041616513","display_name":"Pierre Delanaye","orcid":"https://orcid.org/0000-0002-1480-5761","observed_orcids":["https://orcid.org/0000-0002-1480-5761"]},"institutions":[{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierre Delanaye","raw_affiliation_strings":["Service de N\u00e9phrologie, Dialyse et Transplantation, CHU Li\u00e8ge, Belgique"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de N\u00e9phrologie, Dialyse et Transplantation, CHU Li\u00e8ge, Belgique","institution_ids":["https://openalex.org/I4210134544"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034995895","display_name":"Patrizio Lancellotti","orcid":"https://orcid.org/0000-0002-0804-8194","observed_orcids":["https://orcid.org/0000-0002-0804-8194"]},"institutions":[{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrizio Lancellotti","raw_affiliation_strings":["Service de Cardiologie, CHU Li\u00e8ge, Belgique"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de Cardiologie, CHU Li\u00e8ge, Belgique","institution_ids":["https://openalex.org/I4210134544"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2231,"has_fulltext":true,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.43995768,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":92},"biblio":{"volume":"79","issue":"10","first_page":"676","last_page":"682"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9259999990463257},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.7049999833106995},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9150000214576721},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.8109999895095825},{"id":"https://openalex.org/keywords/heart-failure-with-preserved-ejection-fraction","display_name":"heart failure with preserved ejection fraction","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7590000033378601},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.734000027179718},{"id":"https://openalex.org/keywords/sustain-6","display_name":"SUSTAIN 6","score":0.8180000185966492},{"id":"https://openalex.org/keywords/flow-trial","display_name":"FLOW trial","score":0.949999988079071},{"id":"https://openalex.org/keywords/select-trial","display_name":"SELECT trial","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.9538609981536865},{"id":"https://openalex.org/C148220186","wikidata":"https://www.wikidata.org/wiki/Q7111912","display_name":"Outcome (game theory)","level":2,"score":0.7270053625106812},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3802311420440674},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.17684465646743774},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.08961710333824158},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.08483695983886719},{"id":"https://openalex.org/C144237770","wikidata":"https://www.wikidata.org/wiki/Q747534","display_name":"Mathematical economics","level":1,"score":0.08118101954460144},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.0764981210231781},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000099194","descriptor_name":"Semaglutide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004763","descriptor_name":"Glucagon-Like Peptides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009765","descriptor_name":"Obesity","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:39397557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39397557","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revue medicale de Liege","raw_type":"Journal Article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/325026","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/325026","pdf_url":"https://orbi.uliege.be/bitstream/2268/325026/1/ScheenRevMedLiege2024.pdf","source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revue M\u00e9dicale de Li\u00e8ge, 79 (10), 676 - 682 (2024-10)","raw_type":"editorial reviewed"}],"best_oa_location":{"id":"pmh:oai:orbi.ulg.ac.be:2268/325026","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/325026","pdf_url":"https://orbi.uliege.be/bitstream/2268/325026/1/ScheenRevMedLiege2024.pdf","source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Revue M\u00e9dicale de Li\u00e8ge, 79 (10), 676 - 682 (2024-10)","raw_type":"editorial reviewed"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403405973.pdf","grobid_xml":"https://content.openalex.org/works/W4403405973.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W2519510391","https://openalex.org/W2579419638","https://openalex.org/W2606536757","https://openalex.org/W2785139619","https://openalex.org/W2994626215","https://openalex.org/W3031269238","https://openalex.org/W3141437290","https://openalex.org/W3207079769","https://openalex.org/W4200632540","https://openalex.org/W4206445899","https://openalex.org/W4283456543","https://openalex.org/W4297021616","https://openalex.org/W4311330119","https://openalex.org/W4315754491","https://openalex.org/W4327675375","https://openalex.org/W4361219083","https://openalex.org/W4386154055","https://openalex.org/W4386757987","https://openalex.org/W4388592674","https://openalex.org/W4389155882","https://openalex.org/W4390889238","https://openalex.org/W4392242464","https://openalex.org/W4393255879","https://openalex.org/W4394061375","https://openalex.org/W4394785699","https://openalex.org/W4396850943","https://openalex.org/W4398194417","https://openalex.org/W4398781461","https://openalex.org/W4399012115","https://openalex.org/W4399437557","https://openalex.org/W4399940216","https://openalex.org/W4399985802","https://openalex.org/W4400770067","https://openalex.org/W4402066342","https://openalex.org/W4402066678","https://openalex.org/W4402101139","https://openalex.org/W4402501347","https://openalex.org/W4402942708"],"related_works":["https://openalex.org/W2793359296","https://openalex.org/W3029188122","https://openalex.org/W2908397509","https://openalex.org/W4400126433","https://openalex.org/W7204070526","https://openalex.org/W4289976427","https://openalex.org/W2792638657","https://openalex.org/W2610485642","https://openalex.org/W2809169680","https://openalex.org/W4409502957"],"abstract_inverted_index":{"Injectable":[0],"semaglutide":[1,66,85,161],"at":[2,88,163],"a":[3,127,141],"dose":[4,143],"of":[5,65,144,167],"1":[6],"mg":[7],"once":[8],"weekly":[9],"has":[10],"been":[11],"shown":[12],"to":[13],"be":[14],"the":[15,25,32,45,55,61,157],"most":[16],"efficacious":[17],"glucagon-like":[18],"peptide-1":[19],"receptor":[20],"agonist":[21],"when":[22],"considering":[23],"both":[24],"improvement":[26],"in":[27,34,37,49,67,86,136],"blood":[28],"glucose":[29],"control":[30],"and":[31,71,95,104,117,126],"reduction":[33],"body":[35],"weight":[36],"patients":[38,68,92,137,166],"with":[39,69,84,93,102,107,111,119,138,160],"type":[40],"2":[41],"diabetes":[42],"(T2D).":[43],"After":[44],"SUSTAIN-6":[46],"study,":[47],"published":[48],"2016,":[50],"which":[51],"demonstrated":[52],"not":[53],"only":[54],"good":[56],"safety":[57],"but":[58],"also":[59],"already":[60],"cardiovascular":[62,130,168],"(CV)":[63],"efficacy":[64],"T2D":[70,94,114],"high":[72,164],"CV":[73],"risk,":[74],"several":[75],"large":[76],"placebo-controlled":[77],"randomised":[78],"trials":[79],"have":[80],"confirmed":[81,128],"improved":[82],"prognosis":[83],"different":[87],"risk":[89,165],"populations":[90],":":[91],"chronic":[96],"kidney":[97],"disease":[98,131],"(FLOW":[99],"trial),":[100],"subjects":[101],"obesity":[103,122,139],"heart":[105],"failure":[106],"preserved":[108],"ejection":[109],"fraction,":[110],"or":[112,121],"without":[113,124],"(STEP-HFpEF":[115],"trial)":[116],"people":[118],"overweight":[120],"(but":[123],"T2D)":[125],"atheromatous":[129],"(SELECT":[132],"trial).":[133],"Studies":[134],"performed":[135],"used":[140],"higher":[142],"2.4":[145],"mg/week.":[146],"These":[147],"positive":[148],"results,":[149],"based":[150],"upon":[151],"major":[152],"clinically":[153],"relevant":[154],"outcomes,":[155],"extend":[156],"therapeutic":[158],"possibilities":[159],"among":[162],"and/or":[169],"renal":[170],"diseases.":[171]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4403405973","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2024-10-15T00:00:00"}
